These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11086681)

  • 1. C-glycoside based mimics of D-myo-inositol 1,4,5-trisphosphate.
    Rosenberg HJ; Riley AM; Correa V; Taylor CW; Potter BV
    Carbohydr Res; 2000 Oct; 329(1):7-16. PubMed ID: 11086681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both d- and l-Glucose Polyphosphates Mimic d-
    Shipton ML; Riley AM; Rossi AM; Brearley CA; Taylor CW; Potter BVL
    J Med Chem; 2020 May; 63(10):5442-5457. PubMed ID: 32286062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV
    Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplification of adenophostin A defines a minimal structure for potent glucopyranoside-based mimics of D-myo-inositol 1,4,5-trisphosphate.
    Marwood RD; Riley AM; Correa V; Taylor CW; Potter BV
    Bioorg Med Chem Lett; 1999 Feb; 9(3):453-8. PubMed ID: 10091701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
    Riley AM; Correa V; Mahon MF; Taylor CW; Potter BV
    J Med Chem; 2001 Jun; 44(13):2108-17. PubMed ID: 11405648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-myo-inositol-1,4,5-trisphosphate and adenophostin mimics: importance of the spatial orientation of a phosphate group on the biological activity.
    Roussel F; Moitessier N; Hilly M; Chrétien F; Mauger JP; Chapleur Y
    Bioorg Med Chem; 2002 Mar; 10(3):759-68. PubMed ID: 11814866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ; Gou DM; Shieh WR; Chen CS
    Biochemistry; 1994 Sep; 33(38):11586-97. PubMed ID: 7918372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of glucopyranoside-based ligands for D-myo-inositol 1,4,5-trisphosphate receptors.
    Riley AM; Jenkins DJ; Marwood RD; Potter BV
    Carbohydr Res; 2002 Jun; 337(12):1067-82. PubMed ID: 12062522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT; Riley AM; Mills SJ; Lindley CJ; Potter BV; Westwick J
    Mol Pharmacol; 2000 Mar; 57(3):595-601. PubMed ID: 10692501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of potent agonists of the D-myo-inositol 1,4, 5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin A.
    de Kort M; Correa V; Valentijn AR; van der Marel GA; Potter BV; Taylor CW; van Boom JH
    J Med Chem; 2000 Aug; 43(17):3295-303. PubMed ID: 10966748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors.
    Riley AM; Laude AJ; Taylor CW; Potter BV
    Bioconjug Chem; 2004; 15(2):278-89. PubMed ID: 15025523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G
    J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.
    Gregory RB; Hughes R; Riley AM; Potter BV; Wilcox RA; Barritt GJ
    Biochem J; 2004 Jul; 381(Pt 2):519-26. PubMed ID: 15169542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xylopyranoside-based agonists of D-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity.
    Rosenberg HJ; Riley AM; Marwood RD; Correa V; Taylor CW; Potter BVL
    Carbohydr Res; 2001 May; 332(1):53-66. PubMed ID: 11403088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.